Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei

Int J Infect Dis. 2006 Jan;10(1):25-31. doi: 10.1016/j.ijid.2005.06.001. Epub 2005 Nov 11.

Abstract

Background: Acute septicemic melioidosis is associated with systemic release of endotoxin and the proinflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin-1, and interleukin-6. Excessive release of these cytokines may lead to endothelial injury, depletion of naturally occurring endothelial modulators, microvascular thrombosis, organ failure, and death.

Method: Plasma samples drawn at baseline and after initial antimicrobial therapy in 30 patients with suspected acute severe melioidosis were assayed for D-dimer levels, protein C and protein S antigen levels, and antithrombin functional activities.

Results: Both baseline and continued deficiencies of protein C, protein S, and antithrombin were statistically associated with a poor outcome by logistic regression. Baseline D-dimer levels were significantly higher in fatal cases than survivors and correlated inversely with protein C and antithrombin, suggesting both increased fibrin deposition and fibrinolysis.

Conclusion: The inflammatory response to systemic Burkholderia pseudomallei infection leads to depletion of the natural endothelial modulators protein C, protein S, and antithrombin. Both baseline and continued deficiency of these endothelial modulators is predictive of poor outcome in melioidosis.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Antithrombins / analysis
  • Biomarkers / blood
  • Burkholderia pseudomallei*
  • Ceftazidime / administration & dosage
  • Ceftazidime / therapeutic use
  • Cytokines / blood
  • Disease-Free Survival
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Humans
  • Imipenem / administration & dosage
  • Imipenem / therapeutic use
  • Injections, Intravenous
  • Logistic Models
  • Male
  • Melioidosis / diagnosis*
  • Melioidosis / drug therapy
  • Melioidosis / physiopathology
  • Middle Aged
  • Protein C / analysis
  • Protein S / analysis
  • Retrospective Studies
  • Sepsis / diagnosis*
  • Sepsis / drug therapy
  • Sepsis / physiopathology
  • Thailand
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antithrombins
  • Biomarkers
  • Cytokines
  • Fibrin Fibrinogen Degradation Products
  • Protein C
  • Protein S
  • fibrin fragment D
  • Imipenem
  • Ceftazidime